US Business
Nippon to Close U.S. Steel Deal After National-Security Pact With Trump
The Japanese steelmaker agreed to pay $14.1 billion to buy the Pittsburgh company in 2023.
Articles by Erin Slifka
US Business
It Was the World’s Coolest Air Conditioner—Until the Mold Recall
The popular U-shaped window AC made by Midea blew everyone away. Now it’s dealing with the blowback after recalling the hit appliance.
US Business
The World’s Largest Meatpacker Finally Makes Its NYSE Debut
Brazil’s JBS directly listed its shares in the U.S. market, but the meat giant has faced corruption charges and pushback from environmentalists.
US Business
To Feed Power-Wolfing AI, Lawmakers Are Embracing Nuclear
At a House subcommittee hearing this week, legislators and industry executives sought ways to lower hurdles for nuclear plants to fuel data centers.
US Business
KKR Making Competing Bid for Equipment Maker Spectris
The private-equity firm plans to bid against rival Advent International, which submitted a roughly $5 billion proposal.
Health Care
AFC Urgent Care Joplin to Offer Department of Transportation Physicals Starting June 17, 2025
(Joplin, MO) – AFC Urgent Care Joplin is thrilled to announce the launch of Department of Transportation (DOT) physicals for truck drivers, which kick off on June 17, 2025. Priced at $95, these Federal Motor […]
US Business
Boeing Crash in India Is First Fatal Incident Involving a 787 Jet
The crash deals a fresh blow to the beleaguered U.S. plane maker, which has been mired by safety and production issues in recent years.
US Business
Peloton Names Its Latest Marketing Chief as Turnaround Project Continues
The connected fitness company also created the role of chief technology officer to focus on AI.
US Business
Warner Bros. Bondholders to Face Limits on Cooperation Pacts in Company’s Split
The entertainment company is expected to become one of the first borrowers to restrict creditors from forming cooperation groups.
US Business
Senators Propose Ban on Drug Advertising to Consumers
Bernie Sanders and Angus King introduced a bill that would ban pharmaceutical manufacturers from using direct-to-consumer advertising, including social media, to promote their products.